pfizer glp-1 pipeline Argus Turns Bullish on (PFE), Highlights and Oncology Pfizer is racing to get

Primary outcome The primary outcome of this study is the first occurrence of any psychiatric diseases

GLP-1 drugs offer a powerful tool for individuals struggling with obesity who may not be candidates for surgery or who have not achieved success with lifestyle modifications alone

As more and more data becomes available, the cost benefit analysis of these drugs will become impossible to ignore for health insurance companies

In rare cases, surgical intervention may be necessary to restore the stomach to normal functioning

Mechanistic sub-study embedded in an efficacy trial + Incorporate GSM/dryness endpoints (validated questionnaires, clinician assessment, pH) into semaglutide RCTs or pragmatic trials, with pre-specified subgroup analyses by menopausal status and HRT use

The FDA stated it received an unspecified number of adverse event reports linked to compounded semaglutide that were due to dosing errors